Genmanipulation bei Nahrung - Zukunft oder Horror - 500 Beiträge pro Seite

[Loozer]

Neogen Acquires Squire Laboratories
LANSING, Mich., Sept. 5 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it had completed the acquisition of Squire Laboratories, Inc., of Revere, Mass., and 15 veterinary products produced by the company. Neogen will continue to market the products under the Squire Laboratories label.
The terms of the acquisition were approximately $1.0 million in cash. Neogen anticipates sales of Squire products will be approximately $1.0 million in the next 12 months.
"The addition of Squire products will complement Neogen`s existing line of 71 pharmaceutical, nutraceutical and topical products for the animal safety market," said James Herbert, Neogen`s president. "We are pleased to carry on the fine reputation of outstanding products that Squire Laboratories has built since 1967."
Neogen plans to move its acquired assets, and the manufacturing of acquired products, to its animal safety operations in Lexington, Ky. While the relocation is being completed, anticipated to be in 3 to 4 months, orders for Squire products will be accepted and shipped from Revere.
"During the past 33 years, we have developed many outstanding business relationships and have introduced many products that are now in widespread use in the animal industries," said Rico Salerno, Squire Laboratories` president. "The business has grown to the point where it became appropriate to turn it over to a company with greater resources to capitalize on the future potential growth. We are pleased that Neogen has decided to build upon this reputation."
Salerno has established a new company, Atlantic Animal Health, Inc., to continue the production and marketing of one of the products not acquired by Neogen, Fura-Zone. Atlantic Animal Health will continue manufacturing Fura- Zone in the existing facilities in Massachusetts.
Neogen Corporation develops and markets products and services dedicated to food and animal safety. The Company`s Food Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen`s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements and wound care products.
Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward- looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management`s Discussion and Analysis of Financial Condition and Results of Operations in the Company`s most recently filed Form 10-K.

AOAC Validates Neogen`s Reveal(R) E. coli Testing System
LANSING, Mich., Sept. 12 /PRNewswire/
-- Neogen Corporation (Nasdaq: NEOG) announced today that it has received Official Method First Action status from the Association of Official Analytical Chemists International (AOAC) for its rapid test for E. coli O157:H7, a deadly foodborne bacteria.
The AOAC conferred its Official Method First Action status on both Neogen`s 8- and 20-hour versions of the Reveal(R) for E. coli O157:H7 test kit. Neogen`s 8-hour test is the quickest on the market for this pathogen.
"We`re very pleased that AOAC has confirmed the quality of Reveal E. coli test systems," said James Herbert, Neogen`s president. "The validations will allow us to build upon our market-leading status by allowing us access to select laboratories and institutions that prefer AOAC validations."
"The USDA`s Food Safety Inspection Service (FSIS) has been using Neogen`s Reveal E. coli test systems since 1994 to monitor our nation`s meat supply," Herbert continued. "Each time we get a third party validation on any of our tests, it provides further reassurance to our many customers."
AOAC`s Official Method validation requires a minimum of 15 independent laboratories to validate the test kit. The criteria used in awarding the prestigious AOAC First Action Approval include: specificity, sensitivity, false positive/negatives, recovery, comparison to existing reference methods, package insert review and quality policy certification.
"This AOAC validation incorporated FDA, FSIS and Neogen`s 8-hour enrichment schemes, making this the most versatile E. coli O157:H7 test available in the market today," said Chuck Bird, Neogen`s manager of technical services.
Neogen Corporation develops and markets products and services dedicated to food and animal safety. The Company`s Food Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen`s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements and wound care products.
Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward- looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management`s Discussion and Analysis of Financial Condition and Results of Operations in the Company`s most recently filed Form 10-K.

[48434879]

Wo steht denn in dem ganzen Text etwas von GMO`s?
Die Firma hat Testsätze für mikrobiologische Nachweise. Diese werden in der Untersuchung von u.a. Lebensmitteln eingesetzt.
Aber "Genmanipulation" hört sich so schön reißerisch an!

Gruß 48434879